Member Info for Pedrobull

CAML mine copper in Kazakstan and are listed in London, can't POLY follow that model?

I am looking at this now already hold ICGT and OCI which both trade at big discounts also

NB Private Equity Partners Limited is trading at 30% I calculate based on Share Price of 1625p and NAV 2,323p at 31.12.2022

thanks Mac, agreed £1.25M makes a 14% dilution from current 9m market cap

123,061,766.44 USD now

wow £57.8K for 800,000 shares 7.225p

GLA

ii - Institutional investors
pi - private investors

listed on AIM will limit iis

and 416M shares at 0.3p is only £125K so not really going impact or have i got that wrong?

I use Investing.com app to track markets and according to them CWR volume today is 863K and the average 3 month volume is 804K

He can only be a paid deramper or a nut job, I've filtered him now

so the warrants are these 416.666M @ 0.3p

Warrants
The Company is proposing to issue TPI with up to 416,666,667 warrants to subscribe for 416,666,667 new Ordinary Shares ("Broker Warrants"), subject to full subscription under the Broker Option. The Broker Warrants are exercisable at the Placing Price for a period of three years from the date of the general meeting.

I just bought on HL and noticed that message, will prob be selling when they pop though :)

I read HLs message as the stock exchange LSE could suspend like the LSE has done with Evraz

HL says this;
"Some stock exchanges have suspended trading in shares of Russian domiciled businesses. Whilst we are unable to speculate on future suspensions please be aware there is a risk these shares may suspend and/or you may have difficulty trading in them in the future."

Lido is the biggest holding!

https://cointracking.info/portfolio/KR1ListedHoldings

PS - HydraDX not shown

$120,707,000 USD is approx £97,344,000 with cable at 1.24 so maybe the best way to own crypto is right here right now! KR1 Market cap is only £71M

and 1.1M shares traded as of 15:40 today with a 3 month average of 827K

I wonder what stage the application for approval is?

"For its first personalised oncology tool, Physiomics has focused on developing a tool for the personalization of docetaxel dosing in late stage prostate cancer. If it were to be approved by regulatory authorities, the personalised dosing tool could potentially achieve the following benefits without significantly disrupting the current clinical treatment pathway"

And the share price is at an all time high of 456p so not bad compared to a lot of trusts.

yes absolute genius work from HSBC previous guidance was BUY target 320p now HOLD 140p

Tomorrow they'll be telling us it's less than 11 months till Christmas!

Highlights for the year ended 31 December 2022

· Net Asset Value ("NAV") per share of 662 pence and NAV of £1,167 million

· Total NAV return per share of 24% (+128 pence)

· Investments of £269 million and share of proceeds of £244 million

· Year-end cash and available debt of £210 million

· Outstanding commitments of £929 million

· Buy-back and cancellation of 2.2 million shares

no trades at all!